Literature DB >> 28360618

Paliperidone: As a Possible Cause of Pericardial Effusion.

Musa Şahpolat1, Zekeriya Küçükdurmaz2, Önder Kavakçi1, Recep Kurt2.   

Abstract

Paliperidone which is the active metabolite of risperidon is one of the novel antipsychotics. Controlled clinical studies proved its effectiveness on decreasing the positive and negative symptoms of schizophrenia. Some studies and case reports, reported its cardiovascular and cardiometabolic side effects. Cardiac tamponade, that may be mortal, wasn't reported as a side effect with paliperidone usage before. We present a 40 years old female with catatonic schizophrenia for eighteen years, whom was on 6 mg/day paliperidon for 3 years and presented with pericardial tamponade. We suggest that paliperdione may have cardiovascular and cardiometabolic side effects also in therapeutic doses.

Entities:  

Keywords:  Paliperidone; cardiotoxic side effects of antipsychoticse; pericardial effüsion

Year:  2014        PMID: 28360618      PMCID: PMC5353093          DOI: 10.4274/npa.y7061

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  9 in total

1.  Clozapine and sudden death.

Authors:  S Devarajan; S P Kutcher; S M Dursun
Journal:  Lancet       Date:  2000-03-04       Impact factor: 79.321

2.  QT prolongation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite paliperidone.

Authors:  Yutaro Suzuki; Naoki Fukui; Junzo Watanabe; Shin Ono; Takuro Sugai; Nobuto Tsuneyama; Mami Saito; Yoshimasa Inoue; Toshiyuki Someya
Journal:  Hum Psychopharmacol       Date:  2011-12-05       Impact factor: 1.672

3.  Myocarditis and cardiomyopathy associated with clozapine.

Authors:  J G Kilian; K Kerr; C Lawrence; D S Celermajer
Journal:  Lancet       Date:  1999-11-27       Impact factor: 79.321

4.  Prolongation of cardiac ventricular repolarization under paliperidone: how and how much?

Authors:  Patrick Vigneault; Nisrin Kaddar; Sarah Bourgault; Bertrand Caillier; Sylvie Pilote; Dany Patoine; Chantale Simard; Benoit Drolet
Journal:  J Cardiovasc Pharmacol       Date:  2011-06       Impact factor: 3.105

Review 5.  Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

6.  Mechanism of peripheral noradrenergic stimulation by clozapine.

Authors:  I Elman; D S Goldstein; G Eisenhofer; J Folio; A K Malhotra; C M Adler; D Pickar; A Breier
Journal:  Neuropsychopharmacology       Date:  1999-01       Impact factor: 7.853

7.  Clozapine-induced cardiotoxicity: a clinical update.

Authors:  Jamie J Layland; Danny Liew; David L Prior
Journal:  Med J Aust       Date:  2009-02-16       Impact factor: 7.738

8.  Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study.

Authors:  Michael Davidson; Robin Emsley; Michelle Kramer; Lisa Ford; Guohua Pan; Pilar Lim; Mariëlle Eerdekens
Journal:  Schizophr Res       Date:  2007-04-26       Impact factor: 4.939

9.  Hemopericardium and cardiac tamponade in a patient with an elevated international normalized ratio.

Authors:  Joel T Levis; Mucio C Delgado
Journal:  West J Emerg Med       Date:  2009-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.